Cytokine Profiling of Cyst Fluid and Tumor-Associated Macrophages in Cystic Vestibular Schwannoma.
Otol Neurotol.
2023 Dec 1;44(10):1073-1081. doi: 10.1097/MAO.0000000000004032. Epub 2023 Oct 19. PubMed PMID:
37853737; PubMed Central PMCID:
PMC10669777.
Microsurgical Management of Vestibular Schwannoma (Acoustic Neuroma): Facial Nerve Outcomes, Radiographic Analysis, Complications, and Long-Term Follow-Up in a Series of 420 Surgeries.
World Neurosurg.
2022 Dec;168:e297-e308. doi: 10.1016/j.wneu.2022.09.125. Epub 2022 Oct 2. PubMed PMID:
36198364.
RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma.
Otolaryngol Head Neck Surg.
2022 Nov;167(5):860-868. doi: 10.1177/01945998221083506. Epub 2022 Mar 1. PubMed PMID:
35230908; PubMed Central PMCID:
PMC9433467.
Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg.
2022 Oct;167(4):705-715. doi: 10.1177/01945998221076110. Epub 2022 Feb 8. PubMed PMID:
35133896.
Haller's Ansa: An Unrecognized Route of Facial Movement After Skull Base Surgery.
Laryngoscope.
2022 Sep;132(9):1750-1752. doi: 10.1002/lary.29932. Epub 2021 Nov 6. Review. PubMed PMID:
34741465.
CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.
Oncotarget.
2022;13:890-904. doi: 10.18632/oncotarget.28254. eCollection 2022. PubMed PMID:
35875610; PubMed Central PMCID:
PMC9295707.
Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma.
Otol Neurotol.
2022 Jul 1;43(6):694-701. doi: 10.1097/MAO.0000000000003556. PubMed PMID:
35761463; PubMed Central PMCID:
PMC9354971.
WP1066 induces cell death in a schwannomatosis patient-derived schwannoma cell line.
Cold Spring Harb Mol Case Stud.
2022 Jun;8(4). doi: 10.1101/mcs.a006178. Print 2022 Jun. PubMed PMID:
35732500; PubMed Central PMCID:
PMC9235848.
Merlin-Deficient Schwann Cells Are More Susceptible to Radiation Injury than Normal Schwann Cells In Vitro.
J Neurol Surg B Skull Base.
2022 Jun;83(3):228-236. doi: 10.1055/s-0040-1722283. eCollection 2022 Jun. PubMed PMID:
35769808; PubMed Central PMCID:
PMC9236706.
Comparison of Speech Test Outcomes After Cochlear Implantation in Patients With and Without Asymmetric Hearing Loss.
Otol Neurotol.
2022 Jun 1;43(5):559-566. doi: 10.1097/MAO.0000000000003515. Epub 2022 Mar 8. PubMed PMID:
35261377.
N95 vs Half-face Respirator Wear in Surgical Trainees: Physiologic and Psychological Effects of Prolonged Use.
OTO Open.
2021 Oct-Dec;5(4):2473974X211065437. doi: 10.1177/2473974X211065437. eCollection 2021 Oct-Dec. PubMed PMID:
34926978; PubMed Central PMCID:
PMC8671672.
Primary Vestibular Schwannoma Cells Activate p21 and RAD51-Associated DNA Repair Following Radiation-Induced DNA Damage.
Otol Neurotol.
2021 Dec 1;42(10):e1600-e1608. doi: 10.1097/MAO.0000000000003322. PubMed PMID:
34420024; PubMed Central PMCID:
PMC8595670.
Molecular and Cellular Mechanisms of Perineural Invasion in Oral Squamous Cell Carcinoma: Potential Targets for Therapeutic Intervention.
Cancers (Basel).
2021 Nov 29;13(23). doi: 10.3390/cancers13236011. Review. PubMed PMID:
34885121; PubMed Central PMCID:
PMC8656475.
Tumor-Associated Macrophages in Vestibular Schwannoma and Relationship to Hearing.
OTO Open.
2021 Oct-Dec;5(4):2473974X211059111. doi: 10.1177/2473974X211059111. eCollection 2021 Oct-Dec. PubMed PMID:
34870062; PubMed Central PMCID:
PMC8638079.
Commentary: Interposition Grafting of the Facial Nerve After Resection of a Large Facial Nerve Schwannoma: 2-Dimensional Operative Video.
Oper Neurosurg (Hagerstown).
2021 Sep 15;21(4):E342-E343. doi: 10.1093/ons/opab254. PubMed PMID:
34235543.
Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance.
Cancers (Basel).
2021 Sep 12;13(18). doi: 10.3390/cancers13184575. Review. PubMed PMID:
34572805; PubMed Central PMCID:
PMC8467596.
Fluorescent Detection of Vestibular Schwannoma Using Intravenous Sodium Fluorescein In Vivo.
Otol Neurotol.
2021 Apr 1;42(4):e503-e511. doi: 10.1097/MAO.0000000000002988. PubMed PMID:
33492057; PubMed Central PMCID:
PMC8590806.
Recent advancements in understanding the role of epigenetics in the auditory system.
Gene.
2020 Nov 30;761:144996. doi: 10.1016/j.gene.2020.144996. Epub 2020 Jul 29. Review. PubMed PMID:
32738421; PubMed Central PMCID:
PMC8168289.
Effect of age, electrode array, and time on cochlear implant impedances.
Cochlear Implants Int.
2020 Nov;21(6):344-352. doi: 10.1080/14670100.2020.1788859. Epub 2020 Jul 8. PubMed PMID:
32640889.
Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.
Otol Neurotol.
2020 Jun;41(5):e529-e537. doi: 10.1097/MAO.0000000000002613. Review. PubMed PMID:
32150022; PubMed Central PMCID:
PMC7547625.
Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro.
Head Neck.
2019 Dec;41(12):4069-4075. doi: 10.1002/hed.25956. Epub 2019 Sep 9. PubMed PMID:
31497919.
Modulation of BDNF-TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion In Vitro.
Anticancer Res.
2019 Nov;39(11):5933-5942. doi: 10.21873/anticanres.13798. PubMed PMID:
31704818.
Laminin-coated electrodes improve cochlear implant function and post-insertion neuronal survival.
Neuroscience.
2019 Jul 1;410:97-107. doi: 10.1016/j.neuroscience.2019.04.048. Epub 2019 May 3. PubMed PMID:
31059743.
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.
Neuro Oncol.
2019 Mar 18;21(4):486-497. doi: 10.1093/neuonc/noz002. PubMed PMID:
30615146; PubMed Central PMCID:
PMC6422635.
Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein.
Otol Neurotol.
2018 Sep;39(8):1053-1059. doi: 10.1097/MAO.0000000000001895. PubMed PMID:
30001282; PubMed Central PMCID:
PMC6095714.
A Xenograft Model of Vestibular Schwannoma and Hearing Loss.
Otol Neurotol.
2018 Jun;39(5):e362-e369. doi: 10.1097/MAO.0000000000001766. PubMed PMID:
29557843; PubMed Central PMCID:
PMC5940567.
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.
Mol Cancer Ther.
2017 Nov;16(11):2387-2398. doi: 10.1158/1535-7163.MCT-17-0417. Epub 2017 Aug 3. PubMed PMID:
28775147.
Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Oncotarget.
2017 May 9;8(19):31666-31681. doi: 10.18632/oncotarget.15912. PubMed PMID:
28427224; PubMed Central PMCID:
PMC5458238.
Effects of Intratympanic Dexamethasone on High-Dose Radiation Ototoxicity In Vivo.
Otol Neurotol.
2017 Feb;38(2):180-186. doi: 10.1097/MAO.0000000000001289. PubMed PMID:
27898607.
Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: A dose response study.
Hear Res.
2016 Jul;337:12-24. doi: 10.1016/j.heares.2016.02.003. Epub 2016 Feb 15. PubMed PMID:
26892906.
Atypical radiographic features of skull base cholesterol granuloma.
Eur Arch Otorhinolaryngol.
2016 Jun;273(6):1425-31. doi: 10.1007/s00405-015-3705-7. Epub 2015 Jul 12. PubMed PMID:
26164292.
Dexamethasone Protects Against Radiation-induced Loss of Auditory Hair Cells In Vitro.
Otol Neurotol.
2015 Dec;36(10):1741-7. doi: 10.1097/MAO.0000000000000850. PubMed PMID:
26485588.
Dexamethasone Protects Against Apoptotic Cell Death of Cisplatin-exposed Auditory Hair Cells In Vitro.
Otol Neurotol.
2015 Sep;36(9):1566-71. doi: 10.1097/MAO.0000000000000849. PubMed PMID:
26375980.
Spiral ganglion cells and macrophages initiate neuro-inflammation and scarring following cochlear implantation.
Front Cell Neurosci.
2015;9:303. doi: 10.3389/fncel.2015.00303. eCollection 2015. PubMed PMID:
26321909; PubMed Central PMCID:
PMC4532929.
Human Temporal Bone Removal: The Skull Base Block Method.
J Neurol Surg B Skull Base.
2015 Aug;76(4):278-80. doi: 10.1055/s-0034-1543972. Epub 2015 Mar 2. PubMed PMID:
26225316; PubMed Central PMCID:
PMC4516741.
Molecular regulation of auditory hair cell death and approaches to protect sensory receptor cells and/or stimulate repair following acoustic trauma.
Front Cell Neurosci.
2015;9:96. doi: 10.3389/fncel.2015.00096. eCollection 2015. Review. PubMed PMID:
25873860; PubMed Central PMCID:
PMC4379916.
Short interfering RNA against Bax attenuates TNFα-induced ototoxicity in rat organ of Corti explants.
Otolaryngol Head Neck Surg.
2013 May;148(5):834-40. doi: 10.1177/0194599813477631. Epub 2013 Feb 11. PubMed PMID:
23401256.
Conservation of hearing and protection of hair cells in cochlear implant patients' with residual hearing.
Anat Rec (Hoboken).
2012 Nov;295(11):1909-27. doi: 10.1002/ar.22574. Epub 2012 Oct 8. Review. PubMed PMID:
23044907.
Dexamethasone treatment of tumor necrosis factor-alpha challenged organ of Corti explants activates nuclear factor kappa B signaling that induces changes in gene expression that favor hair cell survival.
Neuroscience.
2011 Aug 11;188:157-67. doi: 10.1016/j.neuroscience.2011.04.061. Epub 2011 May 7. PubMed PMID:
21571041.
Pediatric airway management in craniofacial trauma.
J Craniofac Surg.
2011 Jul;22(4):1175-8. doi: 10.1097/SCS.0b013e31821c00c3. PubMed PMID:
21778839.
Local drug delivery to conserve hearing: mechanisms of action of eluted dexamethasone within the cochlea.
Cochlear Implants Int.
2011 May;12 Suppl 1:S51-3. doi: 10.1179/146701011X13001035753254. PubMed PMID:
21756473.
Inhibition of the JNK signal cascade conserves hearing against electrode insertion trauma-induced loss.
Cochlear Implants Int.
2010 Jun;11 Suppl 1:104-9. doi: 10.1179/146701010x12671177544104. PubMed PMID:
21756592.
Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms.
Cochlear Implants Int.
2010 Jun;11 Suppl 1:42-55. doi: 10.1179/146701010X12671178390834. PubMed PMID:
21756583.
Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic.
Acta Otolaryngol.
2010 Mar;130(3):308-11. doi: 10.1080/00016480903124655. Review. PubMed PMID:
19579145.
Dexamethasone treatment of naïve organ of Corti explants alters the expression pattern of apoptosis-related genes.
Brain Res.
2009 Dec 8;1301:1-8. doi: 10.1016/j.brainres.2009.08.097. Epub 2009 Sep 9. PubMed PMID:
19747459.
Blocking pro-cell-death signal pathways to conserve hearing.
Audiol Neurootol.
2009;14(6):383-92. doi: 10.1159/000241895. Epub 2009 Nov 16. Review. PubMed PMID:
19923808.
Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling.
Hear Res.
2009 Sep;255(1-2):22-32. doi: 10.1016/j.heares.2009.05.003. Epub 2009 May 13. PubMed PMID:
19442713.
Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes.
Neuroscience.
2008 Nov 19;157(2):405-13. doi: 10.1016/j.neuroscience.2008.09.012. Epub 2008 Sep 11. PubMed PMID:
18838114.
Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear implant electrode array.
Otol Neurotol.
2008 Oct;29(7):1012-9. doi: 10.1097/MAO.0b013e3181859a1f. PubMed PMID:
18818545.
What would you like to do?